<DOC>
	<DOCNO>NCT02526810</DOCNO>
	<brief_summary>The purpose study compare blood glucose control , glycaemic fluctuation oxidative stress Type 2 Diabetes two therapy , one glargine combine oral drug continuous subcutaneous insulin injection .</brief_summary>
	<brief_title>Comparison Glycaemic Fluctuation Oxidative Stress Between Two Short-term Therapies Type 2 Diabetes</brief_title>
	<detailed_description>This study single-center , randomize , control prospective trial . Type 2 diabetic patient randomize 2 group ( Group A Group B ) . Subjects group A would treat use continuous subcutaneous insulin injection insulin lispro , subject group B would treat use glargine oral drug ( metformin gliclazide modify release tablet ) . After achieve target glucose level two different approach 3-5 day , maintain target glucose level 3-5 day . Then Medtronic dynamic blood glucose meter would apply subject 72 hour . The clinical data , demographic information , present history , past history , personal history collect 1st day . In 2nd day last day trial , blood sample patient collect Laboratory Measurements : Cr , uric acid , aminotransferase , lipid profile , white blood cell count , N % , fast plasma glucose , fast C-peptide , insulin , HbA1c standard meal test ( 0.5h-postprandial 2h-postprandial blood glucose level , C peptide insulin , et al . The parameter b-cell function glycemia fluctuation calculate analyzed spss 13.0 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1. investigator diagnose type 2 diabetes ( 1999 WHO diagnosis criterion ) . 2. diagnose type 2 diabetes first time without drug therapy , type 2 diabetes accept insulin near 3 month duration shorter 10 year 3 . Fasting plasma glucose ( FPG ) ≥11.1mmol/L glycated haemoglobin ( HbA1c ) ≥9 % . 4. agree participate study sign inform consent . 1. obvious failure heart , hepatic , kidney function . 2. severe acute chronic complication , associate disease . disease use oral hypoglycemic drug . 3. woman pregnancy plan get pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>glargine</keyword>
	<keyword>continuous subcutaneous insulin injection</keyword>
	<keyword>blood glucose control</keyword>
	<keyword>blood glucose fluctuation</keyword>
	<keyword>Oxidative Stress</keyword>
</DOC>